Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Psych CASC / OSCEConsultation-liaison psychiatry

Psych CASC / OSCE · Consultation-liaison psychiatry

Explaining depression treatment and tamoxifen antidepressant choice — CASC communication station

MRCPsych/FRANZCP-style station: explain depression in cancer, collaborative care, safe antidepressant choice with tamoxifen, suicide risk without stigma, and delirium as a medical syndrome.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 52-year-old woman with breast cancer on tamoxifen has major depression. Her partner is angry that 'psychiatry wants antidepressants that will make the cancer worse' after reading about drug interactions online. She also asks whether feeling she would be 'better off dead' means she is weak, and whether night-time confusion last admission means she is 'losing her mind forever.'

Station brief

Format. Communication station, approximately 7–10 minutes after reading time. You are the psychiatry registrar in the oncology clinic. The patient has major depression and is on tamoxifen; her partner attends.[1][5]

Candidate instructions. Explain that depression in cancer is common and treatable, not a moral failure. Outline collaborative care and a tamoxifen-aware antidepressant plan (avoid strong CYP2D6 inhibitors such as paroxetine/fluoxetine). Address death wishes compassionately with a safety plan. Explain prior night confusion as likely delirium — medical and often temporary — not permanent "madness." Check understanding and agree next steps with oncology.[1][2][3][4]

Candidate scenario

Partner: “I read antidepressants cancel tamoxifen. You are not poisoning her cancer treatment. She says she would be better off dead — is she weak? Last admission she pulled drips at night; is she going insane?” Patient looks tearful and quiet. PHQ-9 is high; no active plan disclosed yet.[1][3][5]

Marking domains

  • Empathy, structure, non-defensive stance
  • Accurate plain-language explanation of depression in cancer
  • Clear interaction literacy: not all antidepressants are equal with tamoxifen; avoid paroxetine/fluoxetine; prefer safer alternatives coordinated with oncology
  • Collaborative care concept (team, monitoring, therapy + medication) without overclaiming survival benefit
  • Suicide risk: take seriously, safety plan, not moralising
  • Delirium explanation: acute medical confusion, often reversible, different from schizophrenia
  • Shared plan and check-back [1][2][3][4]
Reveal assessor key

Open. Introduce role, acknowledge fear about cancer treatment and stigma. “You are both protecting her — let’s sort facts from internet noise.” [5]

Depression. “Major depression is a medical illness that often rides with cancer. It is not weakness. Treating it can improve sleep, energy for treatment, and quality of life.” [5][2]

Tamoxifen interaction. “Some antidepressants strongly block an enzyme (CYP2D6) that activates tamoxifen — especially paroxetine and fluoxetine — and that combination worries us. We can choose other options, for example sertraline or escitalopram or mirtazapine depending on her symptoms, and we will check this with oncology. We are not ignoring the interaction; we are planning around it.” [1]

Care model. “Best results come from collaborative care: regular symptom checks, support from a care team, psychological strategies, and carefully chosen medication — not a one-off prescription.” [2]

Death wish. “When people with cancer feel they would be better off dead, we take that very seriously. It is more common after diagnosis than many realise, and it is a reason for close support and treatment, not shame.” Agree safety steps and urgent review triggers.[3]

Night confusion. “Pulling drips at night with confusion often means delirium — a temporary medical brain state from illness, medicines, or metabolic problems. It is not the same as lifelong schizophrenia. We treat causes carefully; strong sedating antipsychotics are not automatic and can sometimes worsen things in palliative settings.” [4]

Close. Summarise plan, invite questions, name contact, document, involve oncology pharmacist if needed.[1][5]

References

  1. [1]Kelly CM, Juurlink DN, Gomes T, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study BMJ, 2010.PMID 20142325
  2. [2]Sharpe M, Walker J, Holm Hansen C, et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial Lancet, 2014.PMID 25175478
  3. [3]Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis N Engl J Med, 2012.PMID 22475594
  4. [4]Agar MR, Lawlor PG, Quinn S, et al. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial JAMA Intern Med, 2017.PMID 27918778
  5. [5]Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer BMJ, 2018.PMID 29695476